SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

ACL Australian Clinical Labs Limited

Healthcare · Diagnostics & Research · website · 4,500 employees
$2.79
52wk 1.83 – 3.03
Overall
57.6
Value
69.4
Growth
38.9
Health
40.1
Quality
54.5
Momentum
89.3
Dividend
64.0
Price
About Australian Clinical Labs Limited

Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers cardiac testing, gastroenterology, haematology, chemical pathology, antenatal testing, serology and microbiology, cervical screening, commercial drug and alcohol testing, STI Testing, veterinary pathology, molecular cancer services, clinical trials pathology, advanced genetic testing, functional pathology, histopathology and cytopathology, CPD education programs for clinicians, and allergy and immunology services. It also provides workplace services, environmental screening, and clinical trial services. The company offers its services under the SunDoctors, SouthernSun Pathology, Specialised Trials, BeFunctional Labs, and Gribbles Veterinary Pathology brands. It serves doctors, patients, and corporate clients. The company was founded in 2015 and is headquartered in Clayton, Australia.

Price analytics

Returns

1 day 1.1%
1 week 0.7%
1 month 3.0%
3 months 22.4%
6 months 34.8%
1 year 11.6%
3 years 0.0%

Risk

Volatility (1y ann.) 35.5%
Beta vs ASX 200 0.66
Sharpe (1y) 0.37
VaR 95% (1-day) -3.2%
Max drawdown (1y) -37.2%
Off 1-year high -6.7%

Technicals

RSI(14) 56
vs 50DMA 3.8%
vs 200DMA 18.7%
Trend Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 69.4
Trailing P/E
52
Forward P/E
79
PEG ratio
—
EV / EBITDA
62
Price / Book
63
Price / Sales
100
Growth 38.9
Revenue growth (1y)
48
Revenue CAGR (3y)
0
EPS growth (1y)
100
EPS CAGR (3y)
0
Financial Health 40.1
Net debt / EBITDA
64
Interest coverage (EBIT/interest)
100
Current ratio
0
Debt / Equity
0
Quality (Profitability & Cash Flow) 54.5
Return on equity
75
Return on assets
74
Operating margin
45
Net margin
22
Cash conversion (OCF / net income)
—
Dividend / Income 64.0
Dividend yield (%)
78
Payout ratio
21
FCF dividend cover
100
Momentum 89.3
6-month return vs ASX 200
100
Price vs 200-day average
100
Price vs 50-day average
69
Position in 52-week range
80

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$520.39M
P/E (trailing)
23.25
P/E (forward)
13.70
EPS (trailing)
0.12
Dividend yield
4.7%
Payout ratio
103.4%
Beta
0.83
EV / EBITDA
10.12
Price / Book
3.45
ROE
14.9%
Operating margin
11.2%
Net margin
3.2%
Total cash
$25.66M
Total debt
$337.40M
Current ratio
0.54
Debt / Equity
2.25
Free cash flow
$166.66M
Avg volume
686,473
Latest annual results (FY ending 30 Jun 2025)
  • Revenue$736.15M
  • Gross profit$607.90M
  • Operating income$62.88M
  • Net income$32.43M
  • Diluted EPS0.17
  • Free cash flow$174.39M
  • Net debt$268.94M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4